Prescription Required
Inclusive of all taxes
In Chronic hepatitis C virus (HCV) infection Chronic hepatitis B virus infection is a serious infection of the liver that has been there for at least 6 months and still not cured. Taspiance 135mcg Injection helps treat this infection effectively. It lowers your chances of getting complications such as new infections and improves your quality of life. If this infection is not treated, it can lead to severe liver damage which can cause other life-threatening problems such as liver failure or may be fatal also. In Chronic hepatitis B virus (HBV) infection Taspiance 135mcg Injection helps control the infection and makes the immune system work better. This lowers your chances of getting complications and improves your quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HCV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
Caution is advised when consuming alcohol with Taspiance 135mcg Injection. Please consult your doctor.
Taspiance 135mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Taspiance 135mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Taspiance 135mcg Injection may cause side effects which could affect your ability to drive. Patients may develop dizziness, confusion, somnolence, and fatigue while on Taspiance 135mcg Injection and should be cautioned to avoid driving.
Taspiance 135mcg Injection should be used with caution in patients with kidney disease. Dose adjustment of Taspiance 135mcg Injection may be needed. Please consult your doctor.
Taspiance 135mcg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Taspiance 135mcg Injection may not be needed in these patients. Please consult your doctor. Regular monitoring of liver function tests is advised while you are taking this medicine.
If you miss a dose of Taspiance 135mcg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Roche Products India Pvt Ltd || ₹14.5/tablet (25% cheaper)